LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

“Crisis-Capable Compliance: The CCO at the Crossroads of AI, Ethics, and Leadership”

April 2026CompliancePharmaceutical

Abstract

The role of the Chief Compliance Officer is undergoing a fundamental transformation in the era of artificial intelligence. No longer confined to oversight and enforcement, the CCO is emerging as a strategic leader at the intersection of technology, ethics, and business judgment. As organizations deploy AI at scale, compliance is no longer reactive—it becomes predictive, embedded, and inseparable from innovation itself. For leaders shaped by environments where uncertainty is constant, such as Argentina, emotional intelligence and intuition are not soft skills, they are survival tools. They sharpen judgment, enable faster pattern recognition, and allow leaders to navigate ambiguity with clarity. In the AI era, these human capabilities become a competitive advantage. While algorithms process data, the CCO must interpret intent, assess risk in context, and ensure decisions align not only with regulations, but with values.

Subscribe to reador
PLS Logo Copyright & permissions

Authors

Dolores Guzman

Legal & Compliance Director , Apex America , UK

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Related Papers

Implementing Effective Compliance Programs in Jurisdictions Where the Rule of Law is Weak
Multinational organizations increasingly operate in jurisdictions where the rule of law is weak, inconsistently enforced, or subject to political and economic influence. For pharmaceutical and biotechnology companies, these environments present...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Valentina Lacerca-Allen
Valentina Lacerca-Allen
Title Marketing/ Communication Specialist, Ethiprax LLC., USA
A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs
Counsel involved in developing regulatory compliance programs know that merely looking at the statute and regulations is not enough. They need to look to multiple sources of information to determine...Read more
Portrait image of Jack Sorokin
Jack Sorokin
Adjunct Instructor, Fremont College, USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective
The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more
Portrait image of Leslie Restaino
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
The Perception Risk Vector: Why Optics Matter and How to Manage it in Corporate Compliance
Oftentimes “how it looks” can be as damaging as “what happened.” For regulators, prosecutors, courts, employees, customers, investors, and investigative journalists, organizational ethics is never judged solely through the narrow...Read more
Portrait image of Camélia Gardot
Camélia Gardot
Senior Director of Compliance, Hertz, France